Hester Biosciences Ltd
NSE:HESTERBIO

Watchlist Manager
Hester Biosciences Ltd Logo
Hester Biosciences Ltd
NSE:HESTERBIO
Watchlist
Price: 2 385.45 INR 0.15% Market Closed
Market Cap: 20.3B INR
Have any thoughts about
Hester Biosciences Ltd?
Write Note

Relative Value

The Relative Value of one HESTERBIO stock under the Base Case scenario is 2 448.69 INR. Compared to the current market price of 2 385.45 INR, Hester Biosciences Ltd is Undervalued by 3%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

HESTERBIO Relative Value
Base Case
2 448.69 INR
Undervaluation 3%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
52
vs Industry
54
Median 3Y
6.5
Median 5Y
7
Industry
7.7
Forward
5.9
vs History
4
vs Industry
1
Median 3Y
57.9
Median 5Y
52.7
Industry
22.7
Forward
39.5
vs History
71
vs Industry
4
Median 3Y
59.1
Median 5Y
43.5
Industry
21.6
vs History
9
vs Industry
Median 3Y
-61.1
Median 5Y
-84.7
Industry
25.2
vs History
38
vs Industry
11
Median 3Y
6.3
Median 5Y
6.8
Industry
2.5
vs History
53
vs Industry
44
Median 3Y
6.9
Median 5Y
7.4
Industry
7.7
Forward
6.3
vs History
34
vs Industry
35
Median 3Y
9.9
Median 5Y
9.7
Industry
9
vs History
19
vs Industry
2
Median 3Y
33.8
Median 5Y
28.4
Industry
4.2
Forward
25.2
vs History
30
vs Industry
1
Median 3Y
47.8
Median 5Y
41.8
Industry
4.1
vs History
71
vs Industry
3
Median 3Y
64.2
Median 5Y
46.7
Industry
5.7
vs History
28
vs Industry
2
Median 3Y
-13.1
Median 5Y
-25.1
Industry
3.6
vs History
50
vs Industry
35
Median 3Y
3.2
Median 5Y
3.9
Industry
4.6

Multiples Across Competitors

HESTERBIO Competitors Multiples
Hester Biosciences Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Hester Biosciences Ltd
NSE:HESTERBIO
20.3B INR 6.5 86.5 34.3 45.8
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 083 264.3 -181 004.1 -219 796.6 -217 288.5
US
Abbvie Inc
NYSE:ABBV
312.7B USD 5.6 61.5 15.3 23.6
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 4.9 37.4 17.5 33.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.2B USD 10.9 -242.3 24.1 25.3
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD 4 891.9 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 849.9 -472 -514.1 -500.3
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
81.3B USD 5.9 17.5 15.9 17.7
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.6 -58.7 -53
NL
argenx SE
XBRU:ARGX
34.8B EUR 18.7 -131 -105.5 -76.9
P/E Multiple
Earnings Growth
IN
Hester Biosciences Ltd
NSE:HESTERBIO
Average P/E: 187.9
86.5
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -181 004.1 N/A
US
Abbvie Inc
NYSE:ABBV
61.5
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -242.3
42%
US
Gilead Sciences Inc
NASDAQ:GILD
891.9
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.5
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.6 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -131 N/A
EV/EBITDA Multiple
EBITDA Growth
IN
Hester Biosciences Ltd
NSE:HESTERBIO
Average EV/EBITDA: 19.6
34.3
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 796.6 N/A
US
Abbvie Inc
NYSE:ABBV
15.3
29%
US
Amgen Inc
NASDAQ:AMGN
17.5
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.1
43%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
16%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.1 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.9
35%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -105.5 N/A
EV/EBIT Multiple
EBIT Growth
IN
Hester Biosciences Ltd
NSE:HESTERBIO
Average EV/EBIT: 25.8
45.8
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 288.5 N/A
US
Abbvie Inc
NYSE:ABBV
23.6
88%
US
Amgen Inc
NASDAQ:AMGN
33.1
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.3
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -500.3 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.7
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.9 N/A

See Also

Discover More
Back to Top